以免疫类药物为指导的新抗原的发现和表征,用于个性化癌症免疫疗法

Yangyang Cai1, Manyu Gong2, Mengqian Zeng1

  • 1State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.

Science advances
|May 21, 2025
PubMed
概括

这项研究提出了一个全面的类图谱和一个机器学习管道 (MaNeo) 来识别新抗原. 马尼奥可以准确检测正规和非正规的新抗原,推进个性化癌症免疫疗法.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K